HEADER TRANSFERASE 28-OCT-02 1N3I TITLE CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PNP WITH TRANSITION TITLE 2 STATE ANALOG DADME-IMMH COMPND MOL_ID: 1; COMPND 2 MOLECULE: PURINE NUCLEOSIDE PHOSPHORYLASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: PNP; COMPND 5 EC: 2.4.2.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-23A(+) KEYWDS TRANSITION STATE COMPLEX, TRIMER, PNP, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.LEWANDOWICZ,W.SHI,G.B.EVANS,P.C.TYLER,R.H.FURNEAUX,L.A.BASSO, AUTHOR 2 D.S.SANTOS,S.C.ALMO,V.L.SCHRAMM REVDAT 4 19-DEC-18 1N3I 1 COMPND HETNAM HETSYN FORMUL REVDAT 4 2 1 ATOM REVDAT 3 24-FEB-09 1N3I 1 VERSN REVDAT 2 27-JAN-04 1N3I 1 HETSYN REVDAT 1 30-SEP-03 1N3I 0 JRNL AUTH A.LEWANDOWICZ,W.SHI,G.B.EVANS,P.C.TYLER,R.H.FURNEAUX, JRNL AUTH 2 L.A.BASSO,D.S.SANTOS,S.C.ALMO,V.L.SCHRAMM JRNL TITL OVER-THE-BARRIER TRANSITION STATE ANALOGUES PROVIDE NEW JRNL TITL 2 CHEMISTRIES FOR INHIBITOR DESIGN: THE CASE OF PURINE JRNL TITL 3 NUCLEOSIDE PHOSPHORYLASE JRNL REF BIOCHEMISTRY V. 42 6057 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 12755607 JRNL DOI 10.1021/BI0343830 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 59299 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 6018 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7419 REMARK 3 BIN R VALUE (WORKING SET) : 0.1810 REMARK 3 BIN FREE R VALUE : 0.2180 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 821 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.008 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5676 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 432 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.19000 REMARK 3 B22 (A**2) : -1.19000 REMARK 3 B33 (A**2) : 2.37000 REMARK 3 B12 (A**2) : -0.28000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : -0.0 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.06 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1N3I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-OCT-02. REMARK 100 THE DEPOSITION ID IS D_1000017472. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59925 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03600 REMARK 200 FOR THE DATA SET : 45.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.10500 REMARK 200 FOR SHELL : 10.30 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1G2O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, MAGNESIUM CHLORIDE, TRIS, PH REMARK 280 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.84200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 42.92100 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 42.92100 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 85.84200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS THE TRIMER IN THE ASYMMETRIC REMARK 300 UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -66.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 PRO A 4 REMARK 465 ARG A 5 REMARK 465 PRO A 6 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ASP B 3 REMARK 465 PRO B 4 REMARK 465 ARG B 5 REMARK 465 PRO B 6 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 ASP C 3 REMARK 465 PRO C 4 REMARK 465 ARG C 5 REMARK 465 PRO C 6 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 239 CG CD OE1 OE2 REMARK 470 GLU B 239 CG CD OE1 OE2 REMARK 470 GLU C 239 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 161 115.69 -34.70 REMARK 500 SER A 208 -155.36 -158.69 REMARK 500 THR A 209 -49.32 63.60 REMARK 500 SER B 161 115.11 -36.23 REMARK 500 SER B 208 -154.29 -157.39 REMARK 500 THR B 209 -48.07 63.57 REMARK 500 SER C 161 117.82 -38.75 REMARK 500 SER C 208 -152.74 -154.58 REMARK 500 THR C 209 -47.66 61.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 C 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DIH A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DIH B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DIH C 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G2O RELATED DB: PDB REMARK 900 1G2O CONTAINS MYCOBACTERIUM TUBERCULOSIS PNP WITH IMMH DBREF 1N3I A 1 268 UNP P0A538 PUNA_MYCTU 1 268 DBREF 1N3I B 1 268 UNP P0A538 PUNA_MYCTU 1 268 DBREF 1N3I C 1 268 UNP P0A538 PUNA_MYCTU 1 268 SEQRES 1 A 268 MET ALA ASP PRO ARG PRO ASP PRO ASP GLU LEU ALA ARG SEQRES 2 A 268 ARG ALA ALA GLN VAL ILE ALA ASP ARG THR GLY ILE GLY SEQRES 3 A 268 GLU HIS ASP VAL ALA VAL VAL LEU GLY SER GLY TRP LEU SEQRES 4 A 268 PRO ALA VAL ALA ALA LEU GLY SER PRO THR THR VAL LEU SEQRES 5 A 268 PRO GLN ALA GLU LEU PRO GLY PHE VAL PRO PRO THR ALA SEQRES 6 A 268 ALA GLY HIS ALA GLY GLU LEU LEU SER VAL PRO ILE GLY SEQRES 7 A 268 ALA HIS ARG VAL LEU VAL LEU ALA GLY ARG ILE HIS ALA SEQRES 8 A 268 TYR GLU GLY HIS ASP LEU ARG TYR VAL VAL HIS PRO VAL SEQRES 9 A 268 ARG ALA ALA ARG ALA ALA GLY ALA GLN ILE MET VAL LEU SEQRES 10 A 268 THR ASN ALA ALA GLY GLY LEU ARG ALA ASP LEU GLN VAL SEQRES 11 A 268 GLY GLN PRO VAL LEU ILE SER ASP HIS LEU ASN LEU THR SEQRES 12 A 268 ALA ARG SER PRO LEU VAL GLY GLY GLU PHE VAL ASP LEU SEQRES 13 A 268 THR ASP ALA TYR SER PRO ARG LEU ARG GLU LEU ALA ARG SEQRES 14 A 268 GLN SER ASP PRO GLN LEU ALA GLU GLY VAL TYR ALA GLY SEQRES 15 A 268 LEU PRO GLY PRO HIS TYR GLU THR PRO ALA GLU ILE ARG SEQRES 16 A 268 MET LEU GLN THR LEU GLY ALA ASP LEU VAL GLY MET SER SEQRES 17 A 268 THR VAL HIS GLU THR ILE ALA ALA ARG ALA ALA GLY ALA SEQRES 18 A 268 GLU VAL LEU GLY VAL SER LEU VAL THR ASN LEU ALA ALA SEQRES 19 A 268 GLY ILE THR GLY GLU PRO LEU SER HIS ALA GLU VAL LEU SEQRES 20 A 268 ALA ALA GLY ALA ALA SER ALA THR ARG MET GLY ALA LEU SEQRES 21 A 268 LEU ALA ASP VAL ILE ALA ARG PHE SEQRES 1 B 268 MET ALA ASP PRO ARG PRO ASP PRO ASP GLU LEU ALA ARG SEQRES 2 B 268 ARG ALA ALA GLN VAL ILE ALA ASP ARG THR GLY ILE GLY SEQRES 3 B 268 GLU HIS ASP VAL ALA VAL VAL LEU GLY SER GLY TRP LEU SEQRES 4 B 268 PRO ALA VAL ALA ALA LEU GLY SER PRO THR THR VAL LEU SEQRES 5 B 268 PRO GLN ALA GLU LEU PRO GLY PHE VAL PRO PRO THR ALA SEQRES 6 B 268 ALA GLY HIS ALA GLY GLU LEU LEU SER VAL PRO ILE GLY SEQRES 7 B 268 ALA HIS ARG VAL LEU VAL LEU ALA GLY ARG ILE HIS ALA SEQRES 8 B 268 TYR GLU GLY HIS ASP LEU ARG TYR VAL VAL HIS PRO VAL SEQRES 9 B 268 ARG ALA ALA ARG ALA ALA GLY ALA GLN ILE MET VAL LEU SEQRES 10 B 268 THR ASN ALA ALA GLY GLY LEU ARG ALA ASP LEU GLN VAL SEQRES 11 B 268 GLY GLN PRO VAL LEU ILE SER ASP HIS LEU ASN LEU THR SEQRES 12 B 268 ALA ARG SER PRO LEU VAL GLY GLY GLU PHE VAL ASP LEU SEQRES 13 B 268 THR ASP ALA TYR SER PRO ARG LEU ARG GLU LEU ALA ARG SEQRES 14 B 268 GLN SER ASP PRO GLN LEU ALA GLU GLY VAL TYR ALA GLY SEQRES 15 B 268 LEU PRO GLY PRO HIS TYR GLU THR PRO ALA GLU ILE ARG SEQRES 16 B 268 MET LEU GLN THR LEU GLY ALA ASP LEU VAL GLY MET SER SEQRES 17 B 268 THR VAL HIS GLU THR ILE ALA ALA ARG ALA ALA GLY ALA SEQRES 18 B 268 GLU VAL LEU GLY VAL SER LEU VAL THR ASN LEU ALA ALA SEQRES 19 B 268 GLY ILE THR GLY GLU PRO LEU SER HIS ALA GLU VAL LEU SEQRES 20 B 268 ALA ALA GLY ALA ALA SER ALA THR ARG MET GLY ALA LEU SEQRES 21 B 268 LEU ALA ASP VAL ILE ALA ARG PHE SEQRES 1 C 268 MET ALA ASP PRO ARG PRO ASP PRO ASP GLU LEU ALA ARG SEQRES 2 C 268 ARG ALA ALA GLN VAL ILE ALA ASP ARG THR GLY ILE GLY SEQRES 3 C 268 GLU HIS ASP VAL ALA VAL VAL LEU GLY SER GLY TRP LEU SEQRES 4 C 268 PRO ALA VAL ALA ALA LEU GLY SER PRO THR THR VAL LEU SEQRES 5 C 268 PRO GLN ALA GLU LEU PRO GLY PHE VAL PRO PRO THR ALA SEQRES 6 C 268 ALA GLY HIS ALA GLY GLU LEU LEU SER VAL PRO ILE GLY SEQRES 7 C 268 ALA HIS ARG VAL LEU VAL LEU ALA GLY ARG ILE HIS ALA SEQRES 8 C 268 TYR GLU GLY HIS ASP LEU ARG TYR VAL VAL HIS PRO VAL SEQRES 9 C 268 ARG ALA ALA ARG ALA ALA GLY ALA GLN ILE MET VAL LEU SEQRES 10 C 268 THR ASN ALA ALA GLY GLY LEU ARG ALA ASP LEU GLN VAL SEQRES 11 C 268 GLY GLN PRO VAL LEU ILE SER ASP HIS LEU ASN LEU THR SEQRES 12 C 268 ALA ARG SER PRO LEU VAL GLY GLY GLU PHE VAL ASP LEU SEQRES 13 C 268 THR ASP ALA TYR SER PRO ARG LEU ARG GLU LEU ALA ARG SEQRES 14 C 268 GLN SER ASP PRO GLN LEU ALA GLU GLY VAL TYR ALA GLY SEQRES 15 C 268 LEU PRO GLY PRO HIS TYR GLU THR PRO ALA GLU ILE ARG SEQRES 16 C 268 MET LEU GLN THR LEU GLY ALA ASP LEU VAL GLY MET SER SEQRES 17 C 268 THR VAL HIS GLU THR ILE ALA ALA ARG ALA ALA GLY ALA SEQRES 18 C 268 GLU VAL LEU GLY VAL SER LEU VAL THR ASN LEU ALA ALA SEQRES 19 C 268 GLY ILE THR GLY GLU PRO LEU SER HIS ALA GLU VAL LEU SEQRES 20 C 268 ALA ALA GLY ALA ALA SER ALA THR ARG MET GLY ALA LEU SEQRES 21 C 268 LEU ALA ASP VAL ILE ALA ARG PHE HET PO4 A 301 5 HET DIH A 401 19 HET PO4 B 302 5 HET DIH B 402 19 HET PO4 C 303 5 HET DIH C 403 19 HETNAM PO4 PHOSPHATE ION HETNAM DIH 7-[[(3R,4R)-3-(HYDROXYMETHYL)-4-OXIDANYL-PYRROLIDIN-1- HETNAM 2 DIH IUM-1-YL]METHYL]-3,5-DIHYDROPYRROLO[3,2-D]PYRIMIDIN-4- HETNAM 3 DIH ONE FORMUL 4 PO4 3(O4 P 3-) FORMUL 5 DIH 3(C12 H17 N4 O3 1+) FORMUL 10 HOH *432(H2 O) HELIX 1 1 ASP A 7 GLY A 24 1 18 HELIX 2 2 TRP A 38 GLY A 46 5 9 HELIX 3 3 ALA A 55 LEU A 57 5 3 HELIX 4 4 HIS A 90 GLY A 94 5 5 HELIX 5 5 ASP A 96 VAL A 101 1 6 HELIX 6 6 VAL A 101 ALA A 110 1 10 HELIX 7 7 SER A 161 ASP A 172 1 12 HELIX 8 8 THR A 190 LEU A 200 1 11 HELIX 9 9 THR A 209 ALA A 219 1 11 HELIX 10 10 SER A 242 ALA A 252 1 11 HELIX 11 11 SER A 253 PHE A 268 1 16 HELIX 12 12 ASP B 7 GLY B 24 1 18 HELIX 13 13 TRP B 38 GLY B 46 5 9 HELIX 14 14 ALA B 55 LEU B 57 5 3 HELIX 15 15 HIS B 90 GLY B 94 5 5 HELIX 16 16 ASP B 96 VAL B 101 1 6 HELIX 17 17 VAL B 101 ALA B 110 1 10 HELIX 18 18 SER B 161 ASP B 172 1 12 HELIX 19 19 THR B 190 LEU B 200 1 11 HELIX 20 20 THR B 209 ALA B 219 1 11 HELIX 21 21 SER B 242 ALA B 252 1 11 HELIX 22 22 SER B 253 PHE B 268 1 16 HELIX 23 23 ASP C 7 GLY C 24 1 18 HELIX 24 24 TRP C 38 GLY C 46 5 9 HELIX 25 25 ALA C 55 LEU C 57 5 3 HELIX 26 26 HIS C 90 GLY C 94 5 5 HELIX 27 27 ASP C 96 VAL C 101 1 6 HELIX 28 28 VAL C 101 ALA C 110 1 10 HELIX 29 29 SER C 161 ASP C 172 1 12 HELIX 30 30 THR C 190 LEU C 200 1 11 HELIX 31 31 THR C 209 ALA C 219 1 11 HELIX 32 32 SER C 242 ARG C 267 1 26 SHEET 1 A10 THR A 50 PRO A 53 0 SHEET 2 A10 GLU A 71 ILE A 77 -1 N LEU A 72 O LEU A 52 SHEET 3 A10 HIS A 80 ALA A 86 -1 N HIS A 80 O ILE A 77 SHEET 4 A10 VAL A 30 LEU A 34 1 O VAL A 30 N LEU A 83 SHEET 5 A10 ILE A 114 GLY A 123 1 O ILE A 114 N ALA A 31 SHEET 6 A10 GLU A 222 LEU A 232 1 O GLU A 222 N MET A 115 SHEET 7 A10 PRO A 133 ASN A 141 -1 N VAL A 134 O SER A 227 SHEET 8 A10 ALA A 176 GLY A 182 1 O ALA A 176 N LEU A 135 SHEET 9 A10 LEU A 204 GLY A 206 1 O LEU A 204 N ALA A 181 SHEET 10 A10 ILE A 114 GLY A 123 -1 N GLY A 122 O VAL A 205 SHEET 1 B10 THR B 50 PRO B 53 0 SHEET 2 B10 GLU B 71 ILE B 77 -1 N LEU B 72 O LEU B 52 SHEET 3 B10 HIS B 80 ALA B 86 -1 O HIS B 80 N ILE B 77 SHEET 4 B10 VAL B 30 LEU B 34 1 O VAL B 30 N LEU B 83 SHEET 5 B10 ILE B 114 GLY B 123 1 O ILE B 114 N ALA B 31 SHEET 6 B10 GLU B 222 LEU B 232 1 O GLU B 222 N MET B 115 SHEET 7 B10 PRO B 133 ASN B 141 -1 N VAL B 134 O SER B 227 SHEET 8 B10 ALA B 176 GLY B 182 1 O ALA B 176 N LEU B 135 SHEET 9 B10 LEU B 204 GLY B 206 1 O LEU B 204 N ALA B 181 SHEET 10 B10 ILE B 114 GLY B 123 -1 N GLY B 122 O VAL B 205 SHEET 1 C10 THR C 50 PRO C 53 0 SHEET 2 C10 GLU C 71 ILE C 77 -1 N LEU C 72 O LEU C 52 SHEET 3 C10 HIS C 80 ALA C 86 -1 O HIS C 80 N ILE C 77 SHEET 4 C10 VAL C 30 LEU C 34 1 O VAL C 30 N LEU C 83 SHEET 5 C10 ILE C 114 GLY C 123 1 O ILE C 114 N ALA C 31 SHEET 6 C10 GLU C 222 LEU C 232 1 O GLU C 222 N MET C 115 SHEET 7 C10 PRO C 133 ASN C 141 -1 N VAL C 134 O SER C 227 SHEET 8 C10 ALA C 176 GLY C 182 1 O ALA C 176 N LEU C 135 SHEET 9 C10 LEU C 204 GLY C 206 1 O LEU C 204 N ALA C 181 SHEET 10 C10 ILE C 114 GLY C 123 -1 N GLY C 122 O VAL C 205 CISPEP 1 GLY A 185 PRO A 186 0 0.56 CISPEP 2 GLY B 185 PRO B 186 0 0.23 CISPEP 3 GLY C 185 PRO C 186 0 0.00 SITE 1 AC1 10 GLY A 35 SER A 36 HIS A 68 ARG A 88 SITE 2 AC1 10 HIS A 90 ASN A 119 ALA A 120 SER A 208 SITE 3 AC1 10 DIH A 401 HOH A 561 SITE 1 AC2 10 GLY B 35 SER B 36 HIS B 68 ARG B 88 SITE 2 AC2 10 HIS B 90 ASN B 119 ALA B 120 SER B 208 SITE 3 AC2 10 DIH B 402 HOH B 532 SITE 1 AC3 10 GLY C 35 SER C 36 HIS C 68 ARG C 88 SITE 2 AC3 10 HIS C 90 ASN C 119 ALA C 120 SER C 208 SITE 3 AC3 10 DIH C 403 HOH C 610 SITE 1 AC4 16 HIS A 90 TYR A 92 ALA A 120 ALA A 121 SITE 2 AC4 16 GLY A 122 TYR A 188 GLU A 189 VAL A 205 SITE 3 AC4 16 GLY A 206 MET A 207 THR A 230 ASN A 231 SITE 4 AC4 16 HIS A 243 VAL A 246 PO4 A 301 HOH A 601 SITE 1 AC5 17 HIS B 90 TYR B 92 ALA B 120 ALA B 121 SITE 2 AC5 17 GLY B 122 TYR B 188 GLU B 189 VAL B 205 SITE 3 AC5 17 GLY B 206 MET B 207 THR B 230 ASN B 231 SITE 4 AC5 17 HIS B 243 VAL B 246 PO4 B 302 HOH B 621 SITE 5 AC5 17 PHE C 153 SITE 1 AC6 17 SER C 36 HIS C 90 TYR C 92 ALA C 120 SITE 2 AC6 17 ALA C 121 GLY C 122 TYR C 188 GLU C 189 SITE 3 AC6 17 VAL C 205 GLY C 206 MET C 207 THR C 230 SITE 4 AC6 17 ASN C 231 HIS C 243 VAL C 246 PO4 C 303 SITE 5 AC6 17 HOH C 520 CRYST1 102.842 102.842 128.763 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009724 0.005614 0.000000 0.00000 SCALE2 0.000000 0.011228 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007766 0.00000 MASTER 312 0 6 32 30 0 23 6 0 0 0 63 END